<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Postapproval Methods To Capture Safety and Efficacy Data for Cell and Gene Therapy Products; Draft Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Postapproval Methods To Capture Safety and Efficacy Data for Cell and Gene Therapy Products; Draft Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2025-09-25 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a draft document entitled "Postapproval Methods to Capture Safety and Efficacy Data for Cell and Gene Therapy Products; Draft Guidance for Industry." The draft guidance document discusses methods and approaches for capturing postapproval safety and efficacy data for cell and gene therapy (CGT) products. Given the potential for long-lasting effects of CGT products, and the generally limited number of participa...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2025-18650</p>
    <p><strong>Publication Date:</strong> 2025-09-25</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2025/09/25/2025-18650/postapproval-methods-to-capture-safety-and-efficacy-data-for-cell-and-gene-therapy-products-draft">https://www.federalregister.gov/documents/2025/09/25/2025-18650/postapproval-methods-to-capture-safety-and-efficacy-data-for-cell-and-gene-therapy-products-draft</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2025-18650</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
